Pandemic-Linked Worldwide Declines in Childhood Vaccination Not Yet Recovered
By Elana Gotkine HealthDay Reporter
FRIDAY, Nov. 1, 2024 -- Countries with COVID-19 pandemic-associated reductions in childhood immunization coverage have not yet recovered, according to research published in the Oct. 31 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.
Camille E. Jones, Ph.D., from the CDC in Atlanta, and colleagues present trends in World Health Organization and UNICEF routine vaccination coverage estimates across 194 WHO member countries through 2023.
The researchers found that global coverage with the first and third doses of diphtheria-tetanus-pertussis-containing vaccine (DTPcv; 89 and 84 percent, respectively) and with the first dose of measles-containing vaccine (83 percent) stagnated during 2022 to 2023 and remained lower than levels seen before the pandemic. Approximately half of the world's 14.5 million children who did not receive the first DTPcv dose were in 31 WHO member countries with fragile, conflict-affected and vulnerable (FCV) settings. Countries' overall protection against vaccine-preventable diseases has been improved by introduction of new and underutilized vaccines such as a second measles-containing vaccine dose in the African region.
"The COVID-19 pandemic-associated disruptions in health systems augmented existing gaps and introduced new gaps in immunization coverage worldwide," the authors write. "Progress toward recovery has been uneven across countries, with low-income countries, the African region, and FCV settings having the most urgent need for action."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted November 2024
Further Support and Information on COVID-19
Read this next
Tdap, MenACWY Coverage Increased in Teens From 2023 to 2024
TUESDAY, Aug. 19, 2025 -- From 2023 to 2024, coverage with one or more doses of the tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) and the...
Two Doses of Zoster Vaccine Reduce Risk for Herpes Zoster Ophthalmicus
TUESDAY, Aug. 19, 2025 -- Two doses of recombinant zoster vaccine (RZV) are associated with a reduced risk for herpes zoster ophthalmicus (HZO), acute myocardial infarction, and...
COVID-19 Infection Linked to Accelerated Vascular Aging
MONDAY, Aug. 18, 2025 -- COVID-19 is associated with early vascular aging, as assessed by carotid-femoral pulse wave velocity (PWV), an established biomarker of large artery...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.